A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash-Mob' retrospective study incorporating 961 patients

Br J Haematol. 2022 Jan;196(2):433-437. doi: 10.1111/bjh.17692. Epub 2021 Dec 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmunity
  • Clinical Decision-Making
  • Disease Management
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / adverse effects
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / etiology
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous